These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7105509)

  • 41. [HEMOLYTIC DISEASE OF THE NEWBORN INFANT CAUSED BY ABO INCOMPATIBILITY, DIAGNOSTIC VALUE OF THE BIOLOGICAL TESTS IN THE INFANT].
    GUIMBRETIERE J; TOSCER M
    Transfusion (Paris); 1964; 7():191-201. PubMed ID: 14168284
    [No Abstract]   [Full Text] [Related]  

  • 42. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 43. HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ABO INCOMPATIBILITY: A STUDY OF THE USE OF GROUP O ERYTHROCYTES IN AB PLASMA.
    GOLDARB DL; GINSBERG V; KAUFMAN M; ROBINSON MG; WATSON RJ
    Pediatrics; 1964 Nov; 34():664-9. PubMed ID: 14227646
    [No Abstract]   [Full Text] [Related]  

  • 44. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 45. Carboxyhemoglobin determination in evaluating neonatal jaundice.
    Alden ER; Lynch SR; Wennberg RP
    Am J Dis Child; 1974 Feb; 127(2):214-7. PubMed ID: 4810274
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hemolytic disease of the newborn due to incompatibility of the ABO system. Bilirubin encephalopathy].
    Malaguzzi Valeri O; Sbraccia C; Carapella De Luca E; Di Piero G; Mencarini L; Natoli G; Natoli V; Valeri OM
    Minerva Pediatr; 1967 Sep; 19(36):1678-86. PubMed ID: 5629556
    [No Abstract]   [Full Text] [Related]  

  • 47. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Maternal-fetal blood group incompatibility in the light of recent statistical and immunohematological data].
    Ragonese P; Rizzo F; Ricevuto C; D'Angelo S; Liotti B
    Minerva Ginecol; 1976 Jan; 28(1):26-30. PubMed ID: 815851
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 51. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABO haemolytic disease: an important cause of neonatal morbidity.
    Jadhav M; Devarajan LV
    Indian Pediatr; 1972 May; 9(5):246-51. PubMed ID: 4675282
    [No Abstract]   [Full Text] [Related]  

  • 53. A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO HD).
    Voak D; Bowley CC
    Vox Sang; 1969 Nov; 17(5):321-48. PubMed ID: 5308005
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of multiple nursing interventions (cluster nursing) in ABO hemolytic disease of neonates and evaluation of its effect.
    Wang W; Tang C; Ji QL; Xiu H; Shao H; Yu XM
    J Int Med Res; 2020 Jan; 48(1):300060519887630. PubMed ID: 31939321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Severe hemolytic disease of the newborn as a result of late and undiagnosed alloimmunization--case report].
    Drozdowska-Szymczak A; Czaplińska N; Borek-Dziecioł B; Kociszewska-Najman B; Bartkowiak R; Wielgoś M
    Ginekol Pol; 2014 Mar; 85(3):226-9. PubMed ID: 24783436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 57. Estimation of the albumin binding capacity in Rh immunization. Practical and theoretical interest. Personal experience.
    Streiff F; Vigneron C; Pierson M; Olive D; Genetet B; Pierron N
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):613-4. PubMed ID: 5003296
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 59. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hemolytic disease of newborn].
    Speilmann W
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.